Search - tctmd.com

Displaying 621 - 640 of 720

Sort: Relevancy | Date

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

L.A. McKeown

September 01, 2015

News Industry News

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

August 26, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Daily News

Among Younger Patients, Women More Likely Than Men to Be Readmitted After Acute MI

June 26, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

Study Highlights Discrepancies in STEMI Recognition, Care Between Young Men, Women

Yael L. Maxwell

April 29, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

Caitlin E. Cox

April 09, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

Public Reporting Linked to Less PCI, Higher Mortality in Acute MI Patients

April 03, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Daily News

VELOCITY Published: Peritoneal Cooling Does Not Decrease Infarct Size in STEMI

Yael L. Maxwell

March 04, 2015

News Daily News

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

Yael L. Maxwell

February 19, 2015

News Daily News

MASTER: Posible Ventaja de la Mortalidad con Stents recubiertos con Malla en Pacientes STEMI al cabo de 1 Año

Yael L. Maxwell

February 19, 2015

News Daily News

MASTER：采用网膜支架在1年时可能会给STEMI患者带来益处

Yael L. Maxwell

February 19, 2015

News Daily News

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

January 28, 2015

Advertisement

Ventrix Initiates Clinical Trial of VentriGel™

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients

Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Among Younger Patients, Women More Likely Than Men to Be Readmitted After Acute MI

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Study Highlights Discrepancies in STEMI Recognition, Care Between Young Men, Women

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

Public Reporting Linked to Less PCI, Higher Mortality in Acute MI Patients

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

VELOCITY Published: Peritoneal Cooling Does Not Decrease Infarct Size in STEMI

MASTER: Potential Mortality Advantage With Mesh-Covered Stent in STEMI Patients at 1 Year

MASTER: Posible Ventaja de la Mortalidad con Stents recubiertos con Malla en Pacientes STEMI al cabo de 1 Año

MASTER：采用网膜支架在1年时可能会给STEMI患者带来益处

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content